- Home
- TROO vs FULC Comparison
TROO vs FULC Comparison
Compare TROO & FULC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TROO
- FULC
- Stock Information
- Founded
- TROO 2005
- FULC 2015
- Country
- TROO Hong Kong
- FULC United States
- Employees
- TROO N/A
- FULC N/A
- Industry
- TROO Radio And Television Broadcasting And Communications Equipment
- FULC Biotechnology: Pharmaceutical Preparations
- Sector
- TROO Technology
- FULC Health Care
- Exchange
- TROO Nasdaq
- FULC Nasdaq
- Market Cap
- TROO 215.4M
- FULC 221.5M
- IPO Year
- TROO N/A
- FULC 2019
- Fundamental
- Price
- TROO $1.73
- FULC $2.97
- Analyst Decision
- TROO
- FULC Hold
- Analyst Count
- TROO 0
- FULC 10
- Target Price
- TROO N/A
- FULC $7.44
- AVG Volume (30 Days)
- TROO 10.2K
- FULC 816.2K
- Earning Date
- TROO 12-03-2024
- FULC 11-13-2024
- Dividend Yield
- TROO N/A
- FULC N/A
- EPS Growth
- TROO N/A
- FULC N/A
- EPS
- TROO N/A
- FULC N/A
- Revenue
- TROO $3,569,000.00
- FULC $80,871,000.00
- Revenue This Year
- TROO N/A
- FULC $2,821.96
- Revenue Next Year
- TROO N/A
- FULC N/A
- P/E Ratio
- TROO N/A
- FULC N/A
- Revenue Growth
- TROO N/A
- FULC 2987.86
- 52 Week Low
- TROO $0.73
- FULC $2.86
- 52 Week High
- TROO $4.89
- FULC $13.70
- Technical
- Relative Strength Index (RSI)
- TROO 30.64
- FULC 32.31
- Support Level
- TROO $1.70
- FULC $2.86
- Resistance Level
- TROO $1.90
- FULC $3.94
- Average True Range (ATR)
- TROO 0.20
- FULC 0.22
- MACD
- TROO -0.00
- FULC -0.00
- Stochastic Oscillator
- TROO 7.62
- FULC 10.19
About TROO TROOPS Inc.
TROOPS Inc is a conglomerate group of various businesses with its headquarters based in Hong Kong. The group is principally engaged in money lending business in Hong Kong providing mortgage loans to high quality target borrowers, property investment to generate additional rental income and the development, operation and management of an online financial marketplace that provides one-stop financial technology solutions including API services by leveraging artificial intelligence, large data and blockchain, and cloud computing (SaaS). It derives revenue from Hong Kong and Australia. Majority of its revenue generates from domestic market.
About FULC Fulcrum Therapeutics Inc.
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.